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Abstract
Background: The first two steps in the capping of cellular mRNAs are catalyzed by the enzymes
RNA triphosphatase and RNA guanylyltransferase. Although structural and mechanistic differences
between fungal and mammalian RNA triphosphatases recommend this enzyme as a potential
antifungal target, it has not been determined if RNA triphosphatase is essential for the growth of
fungal species that cause human disease.
Results:  We show by classical genetic methods that the triphosphatase (Pct1) and
guanylyltransferase (Pce1) components of the capping apparatus in the fission yeast
Schizosaccharomyces pombe are essential for growth. We were unable to disrupt both alleles of the
Candida albicans RNA triphosphatase gene CaCET1, implying that the RNA triphosphatase enzyme
is also essential for growth of C. albicans, a human fungal pathogen.
Conclusions: Our results provide the first genetic evidence that cap synthesis is essential for
growth of an organism other than Saccharomyces cerevisiae and they validate RNA triphosphatase
as a target for antifungal drug discovery.
Background
The m7GpppN cap structure is a defining feature of eu-
karyotic mRNA and is required for mRNA stability and
efficient translation. The cap is formed by three enzy-
matic reactions: the 5' triphosphate end of the nascent
pre-mRNA is hydrolyzed to a diphosphate by RNA tri-
phosphatase; the diphosphate end is capped with GMP
by RNA guanylyltransferase; and the GpppN cap is
methylated by RNA (guanine-7-) methyltransferase [1].
Although the three capping reactions are universal in eu-
karyotes, there is a surprising diversity in the genetic or-
ganization of the capping enzymes as well as a complete
divergence in the structure and catalytic mechanism of
the RNA triphosphatase component in "lower" versus
"higher" eukaryotic species [1]. Metazoans and plants
have a two-component capping system consisting of a bi-
functional triphosphatase-guanylyltransferase polypep-
tide and a separate methyltransferase polypeptide,
whereas fungi contain a three-component system con-
sisting of separate triphosphatase, guanylyltransferase,
and methyltransferase gene products. The primary
structures and biochemical mechanisms of the fungal
and mammalian guanylyltransferases and cap methyl-
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transferases are conserved. However, the atomic struc-
tures and catalytic mechanisms of the fungal and
mammalian RNA triphosphatases are completely differ-
ent [2,3]. Thus, it has been suggested that RNA triphos-
phatase is a promising target for antifungal drug
discovery [2].
The triphosphatase (Cet1), guanylyltransferase (Ceg1),
and methyltransferase (Abd1) components of the cap-
ping apparatus are essential for cell growth in the bud-
ding yeast S. cerevisiae[1,4–6]. Mutations of the RNA
triphosphatase Cet1 that abrogate catalytic activity in vit-
ro are lethal in vivo[7–9]; thus, it is reasonable to think
that pharmacological inhibition of Cet1 function in vivo
would impede cell growth. The key question is whether
RNA triphosphatase is a valid drug target in other fungal
species besides Saccharomyces cerevisiae (which is not
a human pathogen) and whether a mechanism-based in-
hibitor of one fungal RNA triphosphatase could be ex-
pected to display broad spectrum activity against
triphosphatases from other fungal species.
To address these issues, we have characterized the RNA
triphosphatases of two other fungi, including the human
pathogen  Candida albicans and the fission yeast
Schizosaccharomyces pombe[10–12]. The fungal tri-
phosphatases, S. cerevisiae Cet1, C. albicans CaCet1 and
S. pombe Pct1, belong to a new family of metal-depend-
ent phosphohydrolases that embraces the triphos-
phatase components of DNA virus and protozoan mRNA
capping systems [1,7,13,14]. The defining features of the
metal-dependent RNA triphosphatases are two glutama-
te-containing motifs that are required for catalysis and
comprise the metal-binding site in the crystal structure
of S. cerevisiae Cet1. The yeast triphosphatase has a nov-
el tertiary structure in which the active site is situated
within a topologically closed hydrophilic tunnel com-
posed of 8 antiparallel β  strands, which are conserved in
CaCet1 and Pct1 [2]. Mutational analysis of Cet1 has
identified 15 individual side chains within the tunnel that
are important for Cet1 function in vitro and in vivo[7–9].
Each of the 8 strands contributes at least one functional
group to the active site. Mutational analysis of the Cand-
ida triphosphatase suggested strongly that the tunnel
fold and the constituents of the active site are similar, if
not identical, in Cet1 and CaCet1 [10].
Here we address the critical question of whether RNA
triphosphatase is essential for cell growth in fungal spe-
cies other than S. cerevisiae. This is not a straw-man is-
sue, given that S. cerevisiae encodes two homologous
RNA triphosphatases (Cet1 and Cth1), of which only Cet1
is essential for capping and cell viability [8,15]. We use
classical genetic approaches to show that the respective
genes encoding RNA triphosphatase and RNA guanylyl-
transferase are essential in S. pombe. Using a novel
method of Enloe et al. [16] to test gene function in diploid
C. albicans, we were unable to disrupt both copies of the
CaCET1 gene, signifying that RNA triphosphatase is also
essential in that species, a significant human pathogen.
Based on these findings, and the presence of a Cet1 ho-
molog in the Apergillus fumigatus proteome, we con-
clude that RNA triphosphatase is a valid target for
antifungal drug development.
Results
RNA Triphosphatase and RNA Guanylyltransferase are Es-
sential in S. pombe
S. pombe RNA triphosphatase Pct1 is a 303-amino acid
polypeptide with a homodimeric quaternary structure
[12]. The pct1+ gene contains a single intron within the
open reading frame [12]. S. pombe RNA guanylyltrans-
ferase Pce1 is a 402-amino acid monomeric protein [20];
there are no introns within the pce1+ gene. Although re-
combinant Pct1 and Pce1 enzymes have been purified
and characterized biochemically, and shown to function
in cap formation when expressed in S. cerevi-
siae[12,20,21], there have been no antecedent genetic
studies of the essentiality of Pct1 or Pce1 in fission yeast.
Here we constructed pct1∆  and pce1∆  plasmids contain-
ing 5' and 3' flanking genomic sequences in which the en-
tire triphosphatase or guanylyltransferase coding
sequence was deleted and replaced by the kanamycin re-
sistance gene [17]. The pct1::kanMX and pce1::kanMX
constructs were transformed separately into a diploid
strain of S. pombe and chromosomal integrants contain-
ing one copy of the wild-type gene and one of pct1::kan-
MX or pce1::kanMX w e r e  s e l e c t e d  o n  m e d i u m
containing G418. Correct integration was confirmed by
diagnostic PCR amplification of genomic DNA from the
heterozygotes. We then sporulated the heterozygotes,
dissected tetrads, and scored for spore viability and the
presence of the kanMX marker. We found for both
knock-outs that 20 out of 20 tetrads yielded only 2 viable
spores and all of the viable haploids were G418-sensitive,
i.e., none contained the pct1::kanMX or pce1::kanMX
alleles. We conclude that the RNA triphosphatase and
RNA guanylyltransferase genes are essential for cell
growth in S. pombe.
Plasmid-based complementation of pct1∆  and pct1∆
The pct1+ and pce1+ cDNAs were cloned separately into
the S. pombe expression vector pREP41X (LEU2 ars1+)
so as to place them under the control of the nmt1* pro-
moter. We also cloned the intron-containing chromo-
somal pct1+ gene into the same expression vector. The
plasmids were introduced into heterozygous pct1+/
pct1::kanMX or pce1+/pce1::kanMX diploids. The Leu+
diploid transformants were selected and then sporulat-
ed. A random population of Leu+ haploids was tested forBMC Microbiology 2001, 1:29 http://www.biomedcentral.com/1471-2180/1/29
G418-resistance or sensitivity (Table 1). We found that
half of the Leu+ haploids derived from a pct1+/
pct1::kanMX strains containing a plasmid with either
the pct1+ cDNA or pct1+ gene (with intron) also con-
tained the pct1::kanMX chromosomal allele and were
resistant to G418. Similarly, half of the Leu+ haploids de-
rived from a pce+/pce1::kanMX strain containing the
pce1+ plasmid were resistant to G418. In contrast, none
of the Leu+ haploids derived from pct1+/pct1::kanMX or
pce1+/pce1::kanMX strains containing the control LEU2
plasmid vector lacking an insert were G418-resistant.
These results show that the pct1∆  and pce1∆  strains are
viable if the chromosomal deletions are complemented
by an extrachromosomal triphosphatase or guanylyl-
transferase gene. There was no apparent difference in
complementation of pct1∆  by the intron-containing
pct1+ gene versus the pct1+ cDNA.
Although the plasmid-encoded capping enzyme genes
are under the control of a regulated nmt1* promoter,
which can be repressed by inclusion of 5 µg/ml thiamine
in the growth medium [19], we observed that the growth
of the plasmid-dependent strains was not affected by ex-
ogenous thiamine. We suspect that expression levels of
the Pct1 or Pce1 enzymes in these strains exceeded a
threshold required for cell viability.
Test of CaCET1 Essentiality in C. albicans
Candida albicans strains are diploid and do not undergo
meiotic division. Thus, the classical approach of allelic
disruption in diploid cells followed by sporulation and
segregation analysis of haploids is not applicable to the
analysis of gene function in C. albicans. Tests of gene es-
sentiality in Candida necessitate serial disruption of
both alleles using two different selection markers. If the
gene of interest is nonessential, a homozygous diploid
disruptant can be isolated. However, if the gene is essen-
tial, it will be impossible to disrupt both alleles. Mitchell
and colleagues [16] have developed a single-transforma-
tion method to test gene function in diploid C. albicans
that entails the following steps, which we have applied to
First we constructed a deletion allele plasmid containing
5' and 3' genomic sequence flanking the target CaCET1
gene and an intervening marker cassette (ura3∆ 3'-
ARG4-ura3∆ 5', referred to as UAU1) composed of the C.
albicans ARG4 gene flanked by overlapping 5' and 3'
fragments of the URA3 gene. This construct deletes the
coding sequence for amino acids 206 to 506 of the 520-
aa CaCet1 polypeptide. The deleted segment contains the
catalytic domain essential for triphosphatase activity in
vitro and for complementation of the cet1∆  strain of S.
cerevisiae[10,11]. Second, we introduced the linearized
deletion allele into a diploid C. albicans ura3/ura3
arg4/arg4 strain and selected for Arg+ transformants.
Correct insertion via homologous recombination into
one copy of the CaCET1 gene, resulting in cacet1::UAU1
(Figure 1), was confirmed by Southern blotting of ge-
nomic DNA digested with diagnostic restriction endonu-
cleases. For example, a probe specific for the 5' end of the
CaCET1 gene (probe A in Figure 1) hybridized to a single
4.4 kbp BglII fragment after restriction digestion of total
DNA from the parental diploid strain, whereas the heter-
ozygote contained an additional 2.7-kbp fragment de-
rived from scission at a novel BglII site located within the
ARG4 component of the UAU1 insert of the disrupted
cacet1::UAU1 allele (Figure 2A, lane P versus lane H).
The 2.7-kbp fragment was also detected with an ARG4-
specific probe (not shown). We found that the hetero-
zygous CaCET1/cacet1::UAU1 strain displayed normal
growth and morphology (not shown).
Third, we grew 54 independent liquid cultures of the het-
erozygotes in nonselective medium and then selected for
cells that were Arg+ and Ura+. Uracil prototrophy re-
Table 1: Plasmid-based Complementation of pct1∆  and pce1∆




pct1+/pct1::kanMX pREP41X 0 24
pREP41X-pct1+ (cDNA) 21 19
pREP41X-pct1+ 22 18
pce1+/pce1::kanMX pREP41X 0 24
pREP41X-pce1+ 22 18
Figure 1
Genotype of the CaCET1/cacet1::UAU1 heterozygote strain of C.
albicans. Illustrated in cartoon form are the configurations of
the wild-type CaCET1 and the cacet1::UAU1 chromosomal
loci in the Arg+ heterozygous diploids. The positions of perti-
nent restriction sites and the CaCET1 5'-specific (A) and 3'-
specific (B) hybridization probes are shown. Also shown is
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quires restitution of the integrity of the disrupted ura3
gene of the UAU1 cassette by recombination between the
overlapping regions of the ura3∆ 3' and ura3∆ 5' frag-
ments with excision of the intervening ARG4 gene [16].
If  CaCET1 were nonessential, then recombination of
UAU1 into the second copy of CaCET1 (to generate
cacet1::UAU1/cacet1::UAU1) followed by excisional re-
combination of ARG4 in one allele to restore URA3 (gen-
erating cacet1::UAU1/cacet1::URA3) would result in the
selected Arg+ Ura+ phenotype with complete loss of the
wild-type CaCET1 locus. However, if CaCET1 is essential
for growth, then all of the Arg+ Ura+ isolates will have
three copies of the CaCET1 locus (cacet1::UAU1/cacet1::
URA3/CaCET1).
We used Southern blotting to determine the genotype of
one randomly selected Arg+ Ura+ derivative from each of
the 54 separate cultures of the heterozygote diploids. The
blots were probed with a 5' specific CaCET1 fragment
(probe A in Figure 1), which detects both the wild-type
CaCET1 allele and the cacet1::UAU1 allele, and with a 3'-
specific CaCET1 fragment (probe B in Figure 1) derived
from the segment deleted during construction of the
cacet1::UAU1 disruption cassette. Note that probe A hy-
bridized to a single 4.4-kbp BglII fragment in both the
parental diploid strain and the heterozygote (Figure 2B,
lanes P and H), thereby verifying that it did not detect the
disrupted allele. We found that 54/54 Arg+ Ura+ isolates
retained the wild-type CaCET1 locus (Figure 2 and data
not shown), implying that CaCET1 is an essential gene.
All 54 isolates also retained the cacet1::UAU1 allele that
was present in the heterozygote (Fig. 2A and data not
shown) and they acquired a new ~5-kbp BglII fragment
that hybridized to 5'-specific CaCET1 probe (Figure 2A
and data not shown). The novel BglII fragment migrated
identically in 53/54 of the strains analyzed. Recombina-
tion within UAU1 to regenerate URA3 eliminates the
BglII site and results in a cacet1::URA3 locus that would
yield an ~5-kbp fragment upon digestion with BglII (Fig-
ure 1). Therefore, we surmise that the vast majority of the
events leading to the Arg+ Ura+ phenotype entailed allel-
ic triplications. This conclusion is supported by addition-
al Southern analyses of ScaI digests and EcoRI/PstI
digests of genomic DNA from the parental diploid, the
heterozygotes, and the 54 Arg+ Ura+ segregants (data not
shown).
We conducted in parallel an analysis of the function of
the C. albicans CES1/ZDS1 gene, which encodes a pro-
tein homologous to the product of the S. cerevisiae
CES1/ZDS1 gene isolated by us and others in various
suppressor screens [[23] and references therein]. We
found that 3/26 Arg+ Ura+ segregants emanating from a
CES1/ces1::UAU1 heterozygote were homozygous for
disruption at both loci (ces1::UAU1/ces1::URA3) and
had lost the wild-type CES1/ZDS1 allele [B. Schwer, un-
published]. This frequency of homozygosity at a nones-
sential locus is similar to that reported by Mitchell's
group (2 out of 30) for homozygous disruption of the C.
albicans CDC25 gene [16]. These results confirm that the
single-transformation test can, in our hands, be used to
identify a nonessential gene and they underscore the in-
ference from the data presented here that RNA triphos-
phatase is essential for growth of C. albicans.
Discussion
Previous genetic analyses establishing the essentiality of
cap formation were performed in the budding yeast S.
Figure 2
Southern blot analysis. DNA isolated from the parental diploid strain (lane P), one of the Arg+ heterozygotes (isolate #19; lane
H), and fourteen independent Arg+ Ura+ segregants were digested with BglII and resolved by agarose gel electrophoresis. A
photograph of the ethidium bromide-stained gel is shown in panel C. The positions and sizes (kbp) of DNA size markers are
indicated on the right. The DNA was transferred to a Hybond membrane, which was serially hybridized to 32P-labeled DNA
probes A (panel A) and B (panel B) derived from the 5' and 3' segments of the CaCET1 gene, respectively.BMC Microbiology 2001, 1:29 http://www.biomedcentral.com/1471-2180/1/29
cerevisiae. It remained to be seen whether the homologs
from other fungal species are also essential for viability.
It is not a foregone conclusion that essentiality or dispen-
sability of a gene product in S. cerevisiae can be extrap-
olated to pathogenic fungi. For example, Cdc25 is not
essential in C. albicans whereas its homolog is essential
in S. cerevisiae[16]. Conversely, the enzyme DNA topoi-
somerase I is nonessential in S. cerevisiae and S. pombe,
but essential for viability in the pathogenic fungus Cryp-
tococcus neoformans[24].
Here we have shown that the RNA triphosphatases Pct1
and CaCet1 are essential for viability of S. pombe and C.
albicans, respectively The conclusion that CaCet1 is es-
sential is based on a finding that none of the 54 inde-
pendent isolates in the single-transformation test were
homozygous for cacet1∆ ; our interpretation is consistent
with criteria established by Mitchell and colleagues for
inference of essentiality using this genetic approach. De
Backer et al. [25] had previously generated a single allele
knockout in C. albicans of the guanylyltransferase com-
ponent of the capping apparatus (Cgt1) using the URA-
blaster technique and noted a variety of pleiotrophic ef-
fects on stress response, hygromycin sensitivity, and col-
ony morphology in the CGT1/cgt1∆  heterozygote, but
they found that the heterozygote was just as virulent as
the wild-type strain in animal models of systemic candi-
diasis. They were unable to recover a homozygous cgt1∆ /
cgt1∆  isolate after a second transformation with the
URA3 disruption cassette after testing 13 transformants.
Although their sample size was not large, their data, to-
gether with the present findings, indicate that the tri-
phosphatase and guanylyltransferase are both essential
for viability of C. albicans.
Conclusions
RNA triphosphatase is an attractive therapeutic target
for fungal infections because: (i) the active site structure
and catalytic mechanism of fungal RNA triphosphatase
are completely different from the RNA triphosphatase
domain of the metazoan capping enzyme and (ii) meta-
zoans encode no identifiable homologs of the fungal
RNA triphosphatases. Thus, a mechanism-based inhibi-
tor of fungal RNA triphosphatase should be highly selec-
tive for the fungal pathogen and have minimal effect on
the human or animal host. This scenario is plausible only
if RNA triphosphatase is essential for growth of patho-
genic fungi that cause human disease (e.g., Candida al-
bicans, Aspergillus fumigatus, Cryptococcus
neoformans, Pneumocystis carinii, etc.). The finding
that the RNA triphosphatase CaCet1 is essential in the
pathogenic fungus C. albicans provides impetus for the
discovery of compounds that inhibit CaCet1 activity.
Searches of public genome databases indicate that As-
pergillus fumigatus (a major invasive pathogen in hu-
mans, with severe morbidity and mortality) encodes a
homolog of Cet1, as does Neurospora crassa. Thus, we
suspect that all fungal species will have metal-dependent
RNA triphosphatases resembling those of S. cerevisiae,
C. albicans and S. pombe.
Methods and materials
Gene disruption in S. pombe
We used a modified version of the long flanking homolo-
gy PCR technique [17] to produce pct1∆  and pce1∆  gene
disruption cassettes in which the open reading frames
were replaced by the kanMX gene. For each gene, a set of
four primers was synthesized: LI, a 20-mer correspond-
ing to the sense-strand sequence of the 5'-flanking region
~1.2 kb upstream of the translation start codon of pct1+
or pce1+; L2, a 40-mer in which 20 bases were identical
to the 5' sequence of pFA6a-KanMX4 (GCTTCAGCT-
GGCGGCCGCGT) and 20 bases were identical to the an-
tisense strand sequence immediately 5' of the translation
start site of pct1+ or pce1+; L3, a 40-mer in which 20 bas-
es were identical to the 3' sequence of pFA6a-KanMX4
(AGTGGCCTATGCGGCCGCGG) and 20 bases corre-
sponded to the sense-strand sequence immediately 3' of
the stop codon of pct1+ or pce1+; L4, a 20-mer corre-
sponding to the antisense-strand sequence of the 3'-
flanking region ~1 kb downstream of stop codon of pct1+
or pce1+. In the first-stage PCR, a 5'-flanking fragment
was synthesized using S. pombe genomic DNA as the
template and LI plus L2 as primers. The 3' flanking frag-
ment was synthesized using primers L3 and L4. In the
second-stage PCR, aliquots of the purified products from
the first amplification (0.1–0.2 µg) were mixed with 0.5
µg of NotI-digested pFA6a-kanMX4 and amplification
synthesis was primed with the LI and L4 oligonucle-
otides. The products of the second PCR amplification
were gel-purified and subcloned into pGEM-T (Prome-
ga). The recombinants were selected on LB agar medium
containing 100 µg/ml ampicillin and 60 µg/ml kanamy-
cin. The pPCT1∆  and pPCE1∆  plasmid constructs were
confirmed by restriction enzyme digestion and partial
sequencing. The pct1::kanMX cassette was PCR-ampli-
fied from the pPCT1∆  plasmid using primers LI and L4.
The pce1::kanMX cassette was excised from PCE1∆  by
digestion with AatII and NdeI. The cassette fragments
were gel-purified and then used to transform diploid S.
pombe.
The S. pombe diploid strain was generated by crossing
two heterothallic strains FY527(ura4-D18 leuI-32 ade6-
M216 his3-DI h-) and FY528(ura4-D18 leuI-32 ade6-
M210 his3-D1 h+) on ME plates at room temperature. Af-
ter 24 h, the cells were streaked onto medium lacking ad-
enine to select for diploids. The Ade+ diploids were
verified by staining with phloxin B and a single diploid
colony was picked and incubated in 100 ml of YE medi-BMC Microbiology 2001, 1:29 http://www.biomedcentral.com/1471-2180/1/29
um to prepare competent S. pombe cells. The transfor-
mations were performed using the lithium acetate
method [18]. The integrants were selected at 30°C on YE
plates containing 200 µg/ml G418. Single colonies were
restreaked on YE agar containing G418. Genomic DNA
was prepared from individual isolates and the integra-
tion of the pct1::kanMX or pce1::kanMX cassettes into
the correct locus was tested by PCR using diagnostic
primers. The heterozygous diploids were sporulated on
ME plates at room temperature. Tetrads were dissected
from single asci and the spores were incubated at 30°C.
All viable haploids were tested for growth on YES agar
and YES agar containing 200 µg/ml G418.
S. pombe expression vectors for RNA triphosphatase and 
guanylyltransferase
The cDNA encoding Pct1 was amplified from plasmid
pET-PCT1 [12] using primers that introduced an XhoI
site immediately upstream of the translation start codon
and a BamHI site immediately downstream of the stop
codon. The intron-containing chromosomal pct1+ gene
was amplified from total S. pombe genomic DNA. The in-
tron-less pce1+ gene was amplified from plasmid pl32-
PCE1 [12]. The PCR products were digested with XhoI
and BamHI and then inserted into the S. pombe expres-
sion vector pREP41X (LEU2 ars1+) [19]. The inserts
were sequenced to exclude the acquisition of unwanted
mutations during the amplification and cloning steps.
Expression of the capping enzymes from these plasmids
is driven by the nmt1* promoter [19]. The plasmids were
transformed into heterozygous pct1+/pct1::kanMX or
pce1+/pct1::kanMX diploids using the lithium acetate
method [18]. The Leu+ diploid transformants were then
sporulated on ME plates at room temperature. A loopful
of cells was inoculated into 500 µl of sterile water and the
mixture was incubated overnight at 28°C with 10 µl of β -
glucuronidase (Sigma G7770). The spores were plated on
EMM(-Leu) agar medium and incubated at 30°C. Indi-
vidual colonies were then restreaked onto YES agar and
on YES agar containing 200 µg/ml G418. Growth was
scored after incubation for 5 to 7 days at 30°C.
Gene disruption in C. albicans
The CaCET1 gene was disrupted by insertion of a UAU1
cassette [16]. We first constructed plasmid pKS-
5'3'CaCET1, in which a 665-bp PCR fragment derived
from the 5' end of the CaCET1 gene (from nucleotides -
50 to +615 of the open reading frame, with the A residue
of the ATG translation start codon defined as position
+1) was cloned between the KpnI and XbaI sites of pB-
luescript KS+ and a 720-bp fragment extending from po-
sition +1518 of the 1560-nt CaCET1 coding sequence into
the 3' flanking genomic region was inserted between the
SacI and SacII sites of pBluescript KS+ The 3.8-kbp
UAU1 gene was excised from pBME101 with XbaI and
SacII and inserted between the XbaI and SacII sites of
pKS-5'3'CaCET1 to yield pCaCET1::UAU1. This DNA was
linearized with KpnI and SacI and then transformed into
the diploid C. albicans strain BWP17 using the lithium
acetate method. We selected 25 Arg+ transformants and
analyzed them by Southern blotting for integration of the
UAU1 cassette into one of the two CaCET1 chromosomal
loci to yield the heterozygote CaCET1/cacet1::UAU1
configuration depicted in Figure 1. Briefly, genomic DNA
was isolated from the 25 Arg+ strains, then digested with
ScaI (which cuts neither CaCET1 nor UAU1). The digests
were resolved by agarose gel-electrophoresis and trans-
ferred to membranes, which were probed with a radiola-
beled DNA corresponding to the 5' segment of CaCET1
(probe A in Figure 1). Whereas probe A hybridized to a
single 3.8-kbp ScaI fragment in the parental BWP17
strain, the probe detected two fragments in the heterozy-
gote – a 3.8-kbp fragment corresponding to the wild-
type  CaCET1 locus and an ~7.5-kbp fragment corre-
sponding to cacet1::UAU1 (data not shown). This analy-
sis identified 16/25 of the Arg+ transformants as
CaCET1/cacet1::UAU1 heterozygotes. Recombination
rates at the UAU1 gene in the heterozygote were deter-
mined as described by Enloe et al [16]. Ura+ segregants
arose at a rate of 5 x 10-5 per division and Arg+ Ura+ seg-
regants arose at rate of 8 x 10-9 per division.
The sixteen CaCET1/cacet1::UAU1 heterozygotes were
streaked to YPD agar and grown for 3 days at 30°C. A to-
tal of 54 single colonies derived from the 16 heterozy-
gotes were inoculated into separate YPD liquid cultures.
After growth to saturation, aliquots of the cultures were
plated on SD(-Arg-Ura) agar medium. Genomic DNA
was prepared from one Arg+ Ura+ segregant from each
culture and subjected to restriction digestion and South-
ern analysis.
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